scispace - formally typeset
H

Haiying Zhu

Researcher at University of Washington

Publications -  15
Citations -  1215

Haiying Zhu is an academic researcher from University of Washington. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 5, co-authored 7 publications receiving 779 citations.

Papers
More filters
Journal ArticleDOI

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.

TL;DR: The development of vaccines against SARS-CoV-2 would be greatly facilitated by the identification of immunological correlates of protection in humans, as the presence of neutralizing antibodies from prior infection was significantly associated with protection against reinfection.
Journal ArticleDOI

Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit.

TL;DR: All assays tested were found to be highly specific for SARS-CoV-2, with no cross-reactivity with other respiratory viruses observed in the authors' analyses regardless of the primer-probe set or kit used.
Posted ContentDOI

Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate

TL;DR: The development of vaccines against SARS-CoV-2 would be greatly facilitated by the identification of immunological correlates of protection in humans, and the presence of neutralizing antibodies from prior infection was significantly associated with protection against re-infection.
Journal ArticleDOI

Validation of SARS-CoV-2 detection across multiple specimen types.

TL;DR: A modified CDC-based laboratory developed test is able to detect SARSCoV- 2 accurately with similar sensitivity across all sample types tested, and the N2 gene target was found to be most sensitive in CSF.
Posted ContentDOI

Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit.

TL;DR: In the course of optimizing SARS-CoV-2 testing performed by the University of Washington Clinical Virology Lab, it was found that the most sensitive assays were those the used the E-gene primer/probe set described by Corman et al.